Patents by Inventor Hyo-Eun Park

Hyo-Eun Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250354122
    Abstract: The present invention relates to an extracellular vesicle mass production method using a cell spheroid embedded with a microparticle having a differentiation stimulating factor supported therein, and the extracellular vesicle obtained through the production method has the effect of regenerating a tissue, in particular, a cartilage tissue, and, thus, can be used to treat diseases related to tissue regeneration and cartilage by utilizing such effect.
    Type: Application
    Filed: June 12, 2023
    Publication date: November 20, 2025
    Applicant: DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Soo-Hong LEE, Yoshie ARAI, Woong-Jin CHO, Hyo-Eun PARK
  • Patent number: 10311187
    Abstract: A simulation method includes receiving a netlist describing a plurality of devices, performing an arithmetic operation by using values of random telegraph signal (RTS) noise factors respectively corresponding to the plurality of devices, generating an RTS model corresponding to each of the devices, based on a result of the arithmetic operation, and generating a netlist in which the RTS model is reflected.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: June 4, 2019
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Jong-Wook Jeon, Hyo-Eun Park, Keun-Ho Lee, Ui-Hui Kwon, Jong-Chol Kim
  • Patent number: 9833473
    Abstract: Provided are the tolerogenic dendritic cells for treating a myocardial infarction and a method for preparing the same, and more particularly, the tolerogenic dendritic cells for treating a myocardial infarction, which can treat cardiac insufficiency that occurs by excessive remodeling of left ventricle in the heart muscle recovery process after an acute myocardial infarction, and a method for preparing the tolergenic dendritic cells. According to the present invention, the inflammatory reaction and the excessive remodeling of left ventricle in the heart muscle recovery process after a myocardial infarction can be inhibited, and thus, the incidence rate of cardiac insufficiency can be significantly reduced, thereby being effectively used for treating a myocardial infarction.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: December 5, 2017
    Assignee: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Ki-Yuk Chang, Eun-Ho Choo, Hyo-Eun Park, Eun-Hye Park, Dae-Seog Lim, Jun-Ho Lee
  • Publication number: 20170103155
    Abstract: A simulation method includes receiving a netlist describing a plurality of devices, performing an arithmetic operation by using values of random telegraph signal (RTS) noise factors respectively corresponding to the plurality of devices, generating an RTS model corresponding to each of the devices, based on a result of the arithmetic operation, and generating a netlist in which the RTS model is reflected.
    Type: Application
    Filed: October 6, 2016
    Publication date: April 13, 2017
    Inventors: JONG-WOOK JEON, HYO-EUN PARK, KEUN-HO LEE, UI-HUI KWON, JONG-CHOL KIM
  • Publication number: 20160095882
    Abstract: Provided are the tolerogenic dendritic cells for treating a myocardial infarction and a method for preparing the same, and more particularly, the tolerogenic dendritic cells for treating a myocardial infarction, which can treat cardiac insufficiency that occurs by excessive remodeling of left ventricle in the heart muscle recovery process after an acute myocardial infarction, and a method for preparing the tolergenic dendritic cells. According to the present invention, the inflammatory reaction and the excessive remodeling of left ventricle in the heart muscle recovery process after a myocardial infarction can be inhibited, and thus, the incidence rate of cardiac insufficiency can be significantly reduced, thereby being effectively used for treating a myocardial infarction.
    Type: Application
    Filed: October 7, 2014
    Publication date: April 7, 2016
    Inventors: Ki-Yuk Chang, Eun-Ho Choo, Hyo-Eun Park, Eun-Hye Park, Dae-Seog Lim, Jun-Ho Lee